The Long Run with Luke Timmerman

Science & Technology News

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Location:

United States

Genres:

Science & Technology News

Description:

"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

Language:

English

Website:

https://soundcloud.com/longrunpodcast

Episodes

Ep156: David Liu on New Tools and Techniques for Biology

4/16/2024

David Liu, professor of chemistry at Harvard University and co-founder of multiple biotech companies, including Beam Therapeutics and Prime Medicine.

Duration:01:52:57

Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's

3/6/2024

Valerie Daggett, founder and CEO of Seattle-based AltPep, on early detection and treatment of Alzheimer's.

Duration:01:02:37

Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer

2/9/2024

Robert Ang, CEO of Cambridge, Mass.-based Vor Bio, on using CRISPR gene editing to alter bone marrow transplants and improve treatment of acute myeloid leukemia.

Duration:01:03:14

Ep153: Rick Young on Studying Gene Expression for Drug Discovery

1/22/2024

Rick Young, professor at MIT and co-founder of Syros Pharmaceuticals, CAMP4 Therapeutics, Omega Therapeutics, and Dewpoint Therapeutics, on studying gene expression for drug discovery.

Duration:01:01:43

Ep152: Jens Eckstein on Investing in Healthy Aging

1/9/2024

Jens Eckstein, investment partner at Hevolution Foundation, on investing in healthy aging.

Duration:01:05:05

Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer

12/26/2023

Shelley Force Aldred and Nathan Trinklein, co-founders of Rondo Therapeutics, on the opportunity with bispecific antibodies for cancer.

Duration:01:03:55

Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance

12/13/2023

Jeff Jonker, CEO of San Diego-based Belharra Therapeutics, on the renaissance in small molecule drug discovery.

Duration:01:03:48

Ep149: Nancy Stagliano on Precision Neuroscience

11/29/2023

Nancy Stagliano, CEO of South San Francisco-based Neuron23, on bringing precision medicine to neuroscience drug discovery.

Duration:01:01:53

Ep148: Diana Brainard on the Fight Against Infectious Disease

11/13/2023

Diana Brainard, CEO of AlloVir, on leading the fight against infectious diseases.

Duration:01:03:27

Ep147: Reid Huber on Investing in the Future of Medicine

11/1/2023

Reid Huber, partner at Third Rock Ventures, on investing in the future of medicine.

Duration:01:08:41

Ep146: Jeff Huber on Life in Tech and Biotech

10/16/2023

Jeff Huber, co-founder and general partner at Triatomic Capital, on his career path in tech, and then biotech.

Duration:01:47:05

Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer

10/2/2023

Lori Lyons-Williams, CEO of Abdera Therapeutics, on developing targeted radiopharmaceuticals for cancer.

Duration:01:06:39

Ep144: Turning the Tables, Rob Perez Interviews Me

9/19/2023

Turning the Tables, Rob Perez Interviews Me

Duration:01:04:58

Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders

9/6/2023

Zach Weinberg and Alexis Borisy of Curie.Bio on Freeing the Biotech Founders

Duration:01:10:25

Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be

8/24/2023

Fred Appelbaum, a physician, scientist and leader at the Fred Hutchinson Cancer Center, on 'Living Medicine,' his new book about the development of bone marrow transplantation and the rise of cell therapy.

Duration:00:55:54

Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets

8/8/2023

Colin Hill, co-founder and CEO of Aitia, on digging deep into biological datasets and finding new drug targets.

Duration:01:09:30

Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas

7/24/2023

Yung Lie, president and CEO of Damon Runyon Cancer Research Foundation, on advancing cancer research by supporting young scientists with bold and brave ideas.

Duration:01:02:40

Ep139: Kevin Conroy on Early Detection of Cancer

7/10/2023

Kevin Conroy, CEO of Exact Sciences, on early detection of cancer.

Duration:01:08:28

Ep138: Jodie Morrison on Becoming a Biotech CEO

6/27/2023

Jodie Morrison, acting CEO of Q32Bio, on becoming a biotech CEO.

Duration:01:00:17

Ep137: Aaron Ring on Immunotherapy for Cancer & More

6/14/2023

Aaron Ring, a scientist at Yale moving to the Fred Hutchinson Cancer Center, on applying immunology and protein engineering for cancer therapy and more.

Duration:00:56:37